| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 GRM1 SSTR2 OPN1SW F2R OR1L3 OR6K6 GPR179 OR10G7 OR52E2 OR10D3 FZD1 FZD7 OR12D3 GHSR FZD8 OR51E1 NPY4R2 OR4A8 OR11A1 NPY4R OR4A5 FZD5 GPR68 AGTR2 APLNR OR1P1 OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 FZD2 OR51B2 OR52B6 HCRTR1 | 5.44e-48 | 884 | 155 | 66 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR6B1 CHRNA6 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 GRM1 SSTR2 OPN1SW F2R CHRNA1 OR1L3 LEPR CHRNA5 OR6K6 GPR179 CHRNB3 OR10G7 IFNAR1 OR52E2 OR10D3 FZD1 FZD7 OR12D3 GHSR FZD8 OR51E1 NPY4R2 OR4A8 OR11A1 NPY4R OR4A5 FZD5 GPR68 AGTR2 APLNR SCN7A OR1P1 OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 FZD2 OR51B2 OR52B6 HCRTR1 | 7.46e-44 | 1353 | 155 | 73 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 3.15e-20 | 431 | 155 | 30 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 CHRNA6 ABCA4 SLC2A9 SLC38A9 SLCO2B1 BEST2 TRPC4 SLC22A11 SLC26A5 SLC34A2 MFSD4A SLC6A15 SLC22A24 CHRNA1 ABCC6 CHRNA5 SLC22A12 SLC2A5 CHRNB3 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SLC16A6 ABCA6 ABCA5 SLC22A10 SCN7A KCNK10 NIPAL2 ABCC12 SLC25A19 MFSD5 SLC38A6 SLC29A4 SLC4A11 | 3.28e-14 | 1180 | 155 | 38 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 CHRNA6 ABCA4 SLC2A9 SLC38A9 SLCO2B1 BEST2 TRPC4 SLC22A11 SLC26A5 SLC34A2 MFSD4A SLC6A15 ATP10B SLC22A24 CHRNA1 ABCC6 CHRNA5 SLC22A12 SLC2A5 CHRNB3 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SLC16A6 ABCA6 ABCA5 SLC22A10 SCN7A KCNK10 NIPAL2 ABCC12 SLC25A19 MFSD5 SLC38A6 SLC29A4 SLC4A11 | 1.03e-13 | 1289 | 155 | 39 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A18 ABCA4 SLC2A9 SLCO2B1 SLC22A11 SLC26A5 SLC34A2 SLC6A15 ABCC6 SLC6A13 SLC46A3 SLC10A1 SLC30A5 ABCA6 ABCA5 SLC22A10 ABCC12 SLC25A19 SLC29A4 SLC4A11 | 9.21e-10 | 477 | 155 | 20 | GO:0022804 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | CYSLTR2 GALR1 MLNR MCHR2 SSTR2 F2R NPY4R2 NPY4R AGTR2 APLNR HCRTR1 | 7.22e-09 | 133 | 155 | 11 | GO:0008528 |
| GeneOntologyMolecularFunction | peptide receptor activity | CYSLTR2 GALR1 MLNR MCHR2 SSTR2 F2R NPY4R2 NPY4R AGTR2 APLNR HCRTR1 | 1.24e-08 | 140 | 155 | 11 | GO:0001653 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A18 SLC2A9 SLCO2B1 SLC22A11 SLC26A5 SLC34A2 SLC6A15 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SLC22A10 SLC25A19 SLC4A11 | 8.11e-08 | 296 | 155 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.52e-07 | 17 | 155 | 5 | GO:0042813 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A18 CHRNA6 SLC2A9 BEST2 TRPC4 SLC34A2 SLC6A15 CHRNA1 CHRNA5 CHRNB3 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SCN7A KCNK10 NIPAL2 SLC29A4 SLC4A11 | 2.25e-07 | 664 | 155 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A9 SLCO2B1 BEST2 SLC22A11 SLC26A5 SLC6A15 SLC6A13 SLC10A1 SLC16A6 SLC22A10 SLC25A19 SLC38A6 SLC4A11 | 4.98e-07 | 293 | 155 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A18 CHRNA6 SLC2A9 BEST2 TRPC4 SLC26A5 SLC34A2 SLC6A15 CHRNA1 CHRNA5 CHRNB3 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SCN7A KCNK10 NIPAL2 SLC29A4 SLC4A11 | 9.01e-07 | 793 | 155 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC38A9 SLCO2B1 SLC26A5 SLC6A15 SLC6A13 SLC10A1 SLC16A6 SLC22A10 SLC38A6 SLC29A4 | 5.35e-06 | 208 | 155 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | Wnt-protein binding | 6.13e-06 | 34 | 155 | 5 | GO:0017147 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A18 SLC2A9 BEST2 TRPC4 SLC22A11 SLC26A5 SLC34A2 SLC6A15 ABCC6 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SCN7A KCNK10 NIPAL2 MFSD5 SLC4A11 | 6.87e-06 | 758 | 155 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 7.68e-06 | 17 | 155 | 4 | GO:0022848 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC6A18 BEST2 SLC22A11 SLC26A5 SLC34A2 ABCC6 SLC6A13 MFSD5 SLC4A11 | 7.74e-06 | 171 | 155 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | hormone binding | 1.57e-05 | 103 | 155 | 7 | GO:0042562 | |
| GeneOntologyMolecularFunction | symporter activity | SLC6A18 SLC2A9 SLC34A2 SLC6A15 SLC6A13 SLC46A3 SLC10A1 SLC4A11 | 2.28e-05 | 150 | 155 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 2.76e-05 | 23 | 155 | 4 | GO:0015464 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC38A9 SLCO2B1 SLC26A5 SLC6A15 SLC6A13 SLC10A1 SLC16A6 SLC22A10 SLC38A6 | 3.54e-05 | 207 | 155 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.82e-05 | 49 | 155 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 4.57e-05 | 26 | 155 | 4 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 4.57e-05 | 26 | 155 | 4 | GO:0019707 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 4.96e-05 | 123 | 155 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 5.99e-05 | 2 | 155 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | odorant binding | 6.08e-05 | 127 | 155 | 7 | GO:0005549 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 6.72e-05 | 55 | 155 | 5 | GO:0017046 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A18 TRPC4 SLC34A2 SLC6A15 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SCN7A KCNK10 NIPAL2 SLC4A11 | 7.12e-05 | 465 | 155 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 8.18e-05 | 30 | 155 | 4 | GO:0016417 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.11e-04 | 61 | 155 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 1.24e-04 | 13 | 155 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.30e-04 | 100 | 155 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.50e-04 | 196 | 155 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | ethanolaminephosphotransferase activity | 1.79e-04 | 3 | 155 | 2 | GO:0004307 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 1.89e-04 | 37 | 155 | 4 | GO:0016409 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.89e-04 | 37 | 155 | 4 | GO:0042923 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.59e-04 | 73 | 155 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.83e-04 | 41 | 155 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.94e-04 | 75 | 155 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.35e-04 | 119 | 155 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 3.41e-04 | 43 | 155 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 3.44e-04 | 18 | 155 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 3.56e-04 | 4 | 155 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CHRNA6 BEST2 TRPC4 CHRNA1 CHRNA5 CHRNB3 KCNK18 SCN7A KCNK10 SLC4A11 | 3.57e-04 | 343 | 155 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.84e-04 | 171 | 155 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A18 SLC2A9 TRPC4 SLC34A2 SLC6A15 KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SCN7A KCNK10 NIPAL2 SLC4A11 | 3.89e-04 | 627 | 155 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.21e-04 | 81 | 155 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 5.90e-04 | 5 | 155 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 6.34e-04 | 22 | 155 | 3 | GO:0046527 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 6.83e-04 | 90 | 155 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 7.25e-04 | 23 | 155 | 3 | GO:0005283 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 7.61e-04 | 53 | 155 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.93e-04 | 140 | 155 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 9.31e-04 | 25 | 155 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 9.31e-04 | 25 | 155 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.00e-03 | 57 | 155 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.17e-03 | 27 | 155 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.21e-03 | 60 | 155 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | 11-cis retinal binding | 1.23e-03 | 7 | 155 | 2 | GO:0005502 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.37e-03 | 105 | 155 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.45e-03 | 29 | 155 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.45e-03 | 29 | 155 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.61e-03 | 109 | 155 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | CDP-alcohol phosphatidyltransferase activity | 1.63e-03 | 8 | 155 | 2 | GO:0017169 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid binding | 1.63e-03 | 8 | 155 | 2 | GO:0035727 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.64e-03 | 65 | 155 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.64e-03 | 65 | 155 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.93e-03 | 32 | 155 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.93e-03 | 32 | 155 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 2.08e-03 | 9 | 155 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 2.08e-03 | 9 | 155 | 2 | GO:0015143 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 2.08e-03 | 9 | 155 | 2 | GO:0015186 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 2.08e-03 | 9 | 155 | 2 | GO:1901702 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC6A18 SLC2A9 SLC26A5 SLC34A2 SLC6A15 SLC6A13 SLC10A1 SLC30A5 | 2.47e-03 | 301 | 155 | 8 | GO:0022853 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.50e-03 | 35 | 155 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | branched-chain amino acid transmembrane transporter activity | 2.59e-03 | 10 | 155 | 2 | GO:0015658 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.05e-03 | 77 | 155 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 3.14e-03 | 11 | 155 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CHRNA6 BEST2 TRPC4 CHRNA1 CHRNA5 CHRNB3 KCNK18 SCN7A KCNK10 SLC4A11 | 3.17e-03 | 459 | 155 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 3.75e-03 | 12 | 155 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.99e-03 | 83 | 155 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.01e-03 | 193 | 155 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 4.22e-03 | 42 | 155 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.43e-03 | 197 | 155 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.48e-03 | 138 | 155 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.64e-03 | 334 | 155 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 5.12e-03 | 14 | 155 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.12e-03 | 14 | 155 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 5.88e-03 | 15 | 155 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 5.88e-03 | 15 | 155 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 5.88e-03 | 15 | 155 | 2 | GO:0008020 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 6.69e-03 | 16 | 155 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 6.69e-03 | 16 | 155 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 7.54e-03 | 17 | 155 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 7.54e-03 | 17 | 155 | 2 | GO:0009881 | |
| GeneOntologyMolecularFunction | flippase activity | 7.54e-03 | 17 | 155 | 2 | GO:0140327 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ZDHHC21 OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 GRM1 SSTR2 OPN1SW F2R ADCY2 OR1L3 OR6K6 GPR179 OR10G7 OR52E2 OR10D3 FZD1 FZD7 OR12D3 GHSR FZD8 OR51E1 NPY4R2 OR4A8 OR11A1 NPY4R OR4A5 FZD5 GPR68 AGTR2 APLNR OR1P1 OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 FZD2 OR51B2 OR52B6 HCRTR1 | 2.97e-38 | 1395 | 156 | 68 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 BEST2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 FZD2 OR51B2 OR52B6 | 9.95e-22 | 465 | 156 | 32 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 1.67e-20 | 432 | 156 | 30 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception | OR6B1 OR11L1 ABCA4 OR7E24 OR2M7 OR2L3 OR5B2 BEST2 OR1S1 OR1S2 OR4E2 SLC26A5 OR4Q3 OR1A2 OR2M5 OR8U3 GRM1 OPN1SW F2R OR1L3 ABCC6 CHRNA5 OR6K6 GPR179 ALG10B OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 ALG10 OR1P1 OPN5 OR52W1 OR51G1 OR10G8 OR8D4 FZD2 OR51B2 OR52B6 | 5.13e-20 | 1072 | 156 | 43 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 BEST2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 FZD2 OR51B2 OR52B6 | 1.30e-19 | 547 | 156 | 32 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 4.38e-19 | 485 | 156 | 30 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 3.78e-18 | 524 | 156 | 30 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR6B1 OR11L1 ABCA4 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OPN1SW OR1L3 CHRNA5 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OPN5 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 6.73e-18 | 722 | 156 | 34 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 CHRNA5 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 7.56e-18 | 582 | 156 | 31 | GO:0050906 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A18 CHRNA6 SLC2A9 OSTM1 GPER1 SLCO2B1 BEST2 TRPC4 SLC22A11 SLC26A5 STEAP4 SLC34A2 SLC6A15 SLC22A24 F2R CHRNA1 ABCC6 CHRNA5 SLC22A12 CHRNB3 ALG10B CASK KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 ALG10 SLC22A10 APLNR SCN7A KCNK10 NIPAL2 MFSD5 SLC29A4 SLC4A11 | 3.44e-11 | 1374 | 156 | 36 | GO:0006811 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC2A9 SLC38A9 SLCO2B1 BEST2 TRPC4 SLC22A11 SLC26A5 SLC6A15 GRM1 SLC22A24 ABCC6 SLC22A12 SLC6A13 SLC10A1 SLC16A6 SLC22A10 AGTR2 SLC25A19 SLC38A6 SLC4A11 | 2.23e-09 | 515 | 156 | 20 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A18 CHRNA6 SLC2A9 GPER1 BEST2 TRPC4 SLC26A5 STEAP4 SLC34A2 SLC6A15 F2R CHRNA1 ABCC6 CHRNA5 CHRNB3 ALG10B KCNK18 SLC6A13 SLC46A3 SLC30A5 ALG10 APLNR SCN7A KCNK10 NIPAL2 SLC29A4 SLC4A11 | 7.49e-08 | 1115 | 156 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC38A9 SLCO2B1 TRPC4 SLC22A11 SLC26A5 SLC6A15 GRM1 ABCC6 SLC6A13 SLC10A1 SLC16A6 AGTR2 SLC38A6 SLC29A4 | 3.13e-06 | 412 | 156 | 14 | GO:0015849 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 4.03e-06 | 86 | 156 | 7 | GO:0007193 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A18 SLC2A9 GPER1 BEST2 TRPC4 STEAP4 SLC34A2 SLC6A15 F2R CHRNA1 ALG10B CASK KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 ALG10 APLNR SCN7A KCNK10 NIPAL2 SLC29A4 SLC4A11 | 6.48e-06 | 1157 | 156 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A18 SLC2A9 GPER1 BEST2 TRPC4 STEAP4 SLC34A2 SLC6A15 F2R ALG10B KCNK18 SLC6A13 SLC46A3 SLC30A5 ALG10 APLNR SCN7A KCNK10 NIPAL2 SLC29A4 SLC4A11 | 8.90e-06 | 942 | 156 | 21 | GO:0098655 |
| GeneOntologyBiologicalProcess | norepinephrine transport | 9.52e-06 | 38 | 156 | 5 | GO:0015874 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | OXER1 GALR1 HTR5A GPR26 GPER1 FFAR3 GPR42 GPR101 GRM1 SSTR2 ADCY2 | 1.18e-05 | 286 | 156 | 11 | GO:0007188 |
| GeneOntologyBiologicalProcess | organic cation transport | 1.48e-05 | 145 | 156 | 8 | GO:0015695 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC38A9 SLCO2B1 TRPC4 SLC22A11 SLC26A5 SLC6A15 GRM1 ABCC6 SLC6A13 SLC10A1 SLC16A6 AGTR2 SLC38A6 | 1.49e-05 | 410 | 156 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | CHRNA6 ABCA4 GALR1 SLCO2B1 FFAR3 GPR42 SLC22A24 GHSR SLC10A1 ABCA5 AGTR2 SLC29A4 | 1.86e-05 | 358 | 156 | 12 | GO:0015850 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CHRNA6 GPER1 BEST2 FFAR3 GPR42 TRPC4 SLC26A5 GRM1 CHRNA1 CHRNA5 CHRNB3 KCNK18 SCN7A KCNK10 SLC4A11 | 2.33e-05 | 559 | 156 | 15 | GO:0042391 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A18 SLC2A9 GPER1 BEST2 TRPC4 SLC26A5 STEAP4 SLC34A2 SLC6A15 F2R ALG10B KCNK18 SLC6A13 SLC46A3 SLC30A5 ALG10 APLNR SCN7A KCNK10 NIPAL2 SLC4A11 | 2.79e-05 | 1017 | 156 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 2.97e-05 | 24 | 156 | 4 | GO:0018231 | |
| GeneOntologyBiologicalProcess | peptidyl-L-cysteine S-palmitoylation | 2.97e-05 | 24 | 156 | 4 | GO:0018230 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 4.13e-05 | 26 | 156 | 4 | GO:0014061 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 4.44e-05 | 124 | 156 | 7 | GO:0007218 | |
| GeneOntologyBiologicalProcess | fructose transmembrane transport | 4.90e-05 | 10 | 156 | 3 | GO:0015755 | |
| GeneOntologyBiologicalProcess | hard palate development | 4.90e-05 | 10 | 156 | 3 | GO:0060022 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 5.60e-05 | 28 | 156 | 4 | GO:0048243 | |
| GeneOntologyBiologicalProcess | regulation of transmission of nerve impulse | 5.60e-05 | 28 | 156 | 4 | GO:0051969 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A18 GPER1 TRPC4 STEAP4 SLC34A2 SLC6A15 F2R ALG10B CASK KCNK18 SLC6A13 SLC46A3 SLC10A1 SLC30A5 ALG10 APLNR SCN7A KCNK10 NIPAL2 SLC4A11 | 6.84e-05 | 1000 | 156 | 20 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 6.96e-05 | 180 | 156 | 8 | GO:0015698 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A18 SLC2A9 GPER1 TRPC4 STEAP4 SLC34A2 SLC6A15 F2R ALG10B KCNK18 SLC6A13 SLC46A3 SLC30A5 ALG10 APLNR SCN7A KCNK10 NIPAL2 SLC4A11 | 7.11e-05 | 922 | 156 | 19 | GO:0098662 |
| GeneOntologyBiologicalProcess | catecholamine transport | 8.99e-05 | 96 | 156 | 6 | GO:0051937 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 1.09e-04 | 33 | 156 | 4 | GO:0018345 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.15e-04 | 63 | 156 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | protein lipidation | 1.19e-04 | 101 | 156 | 6 | GO:0006497 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 1.54e-04 | 67 | 156 | 5 | GO:0050433 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 1.56e-04 | 106 | 156 | 6 | GO:0042158 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to non-antigenic stimulus | 1.70e-04 | 3 | 156 | 2 | GO:0002879 | |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 1.81e-04 | 15 | 156 | 3 | GO:0098908 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.10e-04 | 112 | 156 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | urate metabolic process | 2.21e-04 | 16 | 156 | 3 | GO:0046415 | |
| GeneOntologyBiologicalProcess | monoamine transport | 2.54e-04 | 116 | 156 | 6 | GO:0015844 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.85e-04 | 167 | 156 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 2.96e-04 | 77 | 156 | 5 | GO:0035567 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.05e-04 | 120 | 156 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 3.33e-04 | 79 | 156 | 5 | GO:0050432 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to non-antigenic stimulus | 3.38e-04 | 4 | 156 | 2 | GO:0002877 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 3.38e-04 | 44 | 156 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | lipid localization | ABCA4 GALR1 AUP1 SLCO2B1 SLC22A11 ATP10B XKR6 SLC22A24 ESYT3 SLC10A1 ABCA6 ABCA5 AGTR2 | 3.73e-04 | 565 | 156 | 13 | GO:0010876 |
| GeneOntologyBiologicalProcess | lipid transport | ABCA4 GALR1 SLCO2B1 SLC22A11 ATP10B XKR6 SLC22A24 ESYT3 SLC10A1 ABCA6 ABCA5 AGTR2 | 4.81e-04 | 506 | 156 | 12 | GO:0006869 |
| GeneOntologyBiologicalProcess | response to thyroid hormone | 5.11e-04 | 21 | 156 | 3 | GO:0097066 | |
| GeneOntologyBiologicalProcess | peptidyl-cysteine modification | 5.53e-04 | 50 | 156 | 4 | GO:0018198 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to non-antigenic stimulus | 5.60e-04 | 5 | 156 | 2 | GO:0002525 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 5.97e-04 | 51 | 156 | 4 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 6.91e-04 | 53 | 156 | 4 | GO:1905145 | |
| GeneOntologyBiologicalProcess | amino acid transport | 7.21e-04 | 195 | 156 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | muscular septum morphogenesis | 8.36e-04 | 6 | 156 | 2 | GO:0003150 | |
| GeneOntologyBiologicalProcess | positive regulation of neuronal action potential | 8.36e-04 | 6 | 156 | 2 | GO:1904457 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 8.52e-04 | 56 | 156 | 4 | GO:1905144 | |
| GeneOntologyBiologicalProcess | action potential | 8.61e-04 | 201 | 156 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 8.95e-04 | 147 | 156 | 6 | GO:0042157 | |
| GeneOntologyBiologicalProcess | response to nicotine | 9.72e-04 | 58 | 156 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | secondary palate development | 1.09e-03 | 27 | 156 | 3 | GO:0062009 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.10e-03 | 60 | 156 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | 1.16e-03 | 7 | 156 | 2 | GO:0007199 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 1.18e-03 | 61 | 156 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | GPER1 TRPC4 STEAP4 SLC34A2 GRM1 F2R CHRNA1 ABCC6 LEPR SLC22A12 SLC30A5 GPR68 AGTR2 APLNR SCN7A HCRTR1 SLC4A11 | 1.24e-03 | 981 | 156 | 17 | GO:0019725 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.49e-03 | 65 | 156 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 1.54e-03 | 8 | 156 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 1.54e-03 | 8 | 156 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 1.56e-03 | 355 | 156 | 9 | GO:0046883 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC2A9 SLCO2B1 BEST2 TRPC4 SLC22A11 SLC26A5 ABCC6 LEPR CASK SLC6A13 SLC10A1 SLC16A6 SLC22A10 SLC29A4 SLC4A11 | 7.61e-08 | 354 | 157 | 15 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC2A9 SLCO2B1 BEST2 TRPC4 SLC26A5 ABCC6 LEPR CASK SLC6A13 SLC10A1 SLC16A6 SLC22A10 SLC29A4 SLC4A11 | 1.43e-07 | 320 | 157 | 14 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | SLC2A9 SLCO2B1 BEST2 TRPC4 SLC22A11 SLC26A5 ABCC6 LEPR CASK SLC6A13 SLC10A1 SLC16A6 SLC22A10 SLC29A4 SLC4A11 | 1.78e-07 | 378 | 157 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | OR2M7 GPER1 AUP1 CAMLG CH25H ZDHHC14 ATP10B OR2M5 ERMP1 ABCC6 OR6K6 ALG10B GDPD5 ESYT3 CEPT1 SPPL2A SCAP SLC30A5 PIGF OR11A1 ZDHHC9 DHCR7 ALG10 ABCC12 PNPLA3 RNF145 DSE | 1.22e-06 | 1293 | 157 | 27 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | OR2M7 GPER1 AUP1 CAMLG CH25H ZDHHC14 ATP10B OR2M5 ERMP1 ABCC6 OR6K6 ALG10B GDPD5 ESYT3 CEPT1 SPPL2A SCAP SLC30A5 PIGF OR11A1 ZDHHC9 DHCR7 ALG10 ABCC12 PNPLA3 RNF145 DSE | 1.33e-06 | 1299 | 157 | 27 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | OR2M7 GPER1 AUP1 CAMLG CH25H ZDHHC14 ATP10B OR2M5 ERMP1 ABCC6 OR6K6 ALG10B GDPD5 ESYT3 CEPT1 SPPL2A SCAP SLC30A5 PIGF OR11A1 ZDHHC9 DHCR7 ALG10 ABCC12 PNPLA3 RNF145 DSE | 2.00e-06 | 1327 | 157 | 27 | GO:0042175 |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 8.63e-06 | 18 | 157 | 4 | GO:0005892 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 5.76e-04 | 22 | 157 | 3 | GO:0098691 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC6A18 SLC2A9 SLCO2B1 SLC22A11 SLC34A2 ABCC6 SLC22A12 SLC2A5 SLC30A5 SLC29A4 SLC4A11 | 1.16e-03 | 487 | 157 | 11 | GO:0016324 |
| MousePheno | abnormal urine homeostasis | SLC6A18 LPAR4 SLC2A9 SLC34A2 GRM1 F2R LEPR SLC22A12 SLC10A1 AGTR2 APLNR SLC25A19 SLC4A11 | 1.53e-05 | 466 | 95 | 13 | MP:0009643 |
| MousePheno | absent cochlear microphonics | 3.52e-05 | 10 | 95 | 3 | MP:0004413 | |
| MousePheno | uraturia | 4.57e-05 | 2 | 95 | 2 | MP:0011537 | |
| Domain | 7tm_1 | OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 SSTR2 OPN1SW F2R OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 GHSR OR51E1 NPY4R2 OR11A1 NPY4R OR4A5 GPR68 AGTR2 APLNR OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 HCRTR1 | 2.52e-41 | 677 | 153 | 56 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 SSTR2 OPN1SW F2R OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 GHSR OR51E1 NPY4R2 OR11A1 NPY4R OR4A5 GPR68 AGTR2 APLNR OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 HCRTR1 | 4.79e-41 | 685 | 153 | 56 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 SSTR2 OPN1SW F2R OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 GHSR OR51E1 NPY4R2 OR11A1 NPY4R OR4A5 GPR68 AGTR2 APLNR OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 HCRTR1 | 7.72e-41 | 691 | 153 | 56 | PS50262 |
| Domain | GPCR_Rhodpsn | OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 GPR42 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 SSTR2 OPN1SW F2R OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 GHSR OR51E1 NPY4R2 OR11A1 NPY4R OR4A5 GPR68 AGTR2 APLNR OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 HCRTR1 | 8.35e-41 | 692 | 153 | 56 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR6B1 OR11L1 CYSLTR2 OXER1 GPR15 OR7E24 OR2M7 GALR1 OR2L3 LPAR4 HTR5A GPR26 GPER1 GPR33 OR5B2 MLNR FFAR3 OR1S1 OR1S2 MCHR2 OR4E2 OR4Q3 GPR141 P2RY8 GPR135 OR1A2 OR2M5 OR8U3 GPR101 SSTR2 OPN1SW F2R OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 GHSR OR51E1 NPY4R2 OR11A1 NPY4R OR4A5 GPR68 AGTR2 APLNR OPN5 OR52W1 CCR6 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 HCRTR1 | 2.37e-40 | 670 | 153 | 55 | IPR017452 |
| Domain | Olfact_rcpt | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 OR51E1 OR11A1 OR4A5 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 1.51e-17 | 393 | 153 | 27 | IPR000725 |
| Domain | MFS_dom | SLC2A9 SLCO2B1 SLC22A11 MFSD4A SLC22A24 SLC22A12 SLC2A5 SLC46A3 SLC16A6 SLC22A10 MFSD5 SLC29A4 | 1.06e-09 | 134 | 153 | 12 | IPR020846 |
| Domain | Frizzled | 1.53e-08 | 11 | 153 | 5 | IPR000539 | |
| Domain | Frizzled | 1.53e-08 | 11 | 153 | 5 | PF01534 | |
| Domain | Frizzled | 1.53e-08 | 11 | 153 | 5 | SM01330 | |
| Domain | MFS | SLC2A9 SLC22A11 MFSD4A SLC22A24 SLC22A12 SLC2A5 SLC46A3 SLC16A6 SLC22A10 MFSD5 | 1.97e-08 | 108 | 153 | 10 | PS50850 |
| Domain | Frizzled/SFRP | 1.40e-07 | 16 | 153 | 5 | IPR015526 | |
| Domain | FRI | 4.85e-07 | 20 | 153 | 5 | SM00063 | |
| Domain | - | 6.32e-07 | 21 | 153 | 5 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 1.30e-06 | 24 | 153 | 5 | IPR020067 | |
| Domain | FZ | 1.30e-06 | 24 | 153 | 5 | PS50038 | |
| Domain | Fz | 1.30e-06 | 24 | 153 | 5 | PF01392 | |
| Domain | MFS_1 | 3.21e-06 | 77 | 153 | 7 | PF07690 | |
| Domain | MFS | 3.21e-06 | 77 | 153 | 7 | IPR011701 | |
| Domain | Nicotinic_acetylcholine_rcpt | 7.30e-06 | 16 | 153 | 4 | IPR002394 | |
| Domain | MFS_sugar_transport-like | 1.06e-05 | 36 | 153 | 5 | IPR005828 | |
| Domain | Sugar_tr | 1.06e-05 | 36 | 153 | 5 | PF00083 | |
| Domain | - | 3.40e-05 | 23 | 153 | 4 | 1.20.120.370 | |
| Domain | zf-DHHC | 3.40e-05 | 23 | 153 | 4 | PF01529 | |
| Domain | Acetylcholine_rcpt_TM | 3.40e-05 | 23 | 153 | 4 | IPR027361 | |
| Domain | 7TM_GPCR_Srsx | 3.81e-05 | 112 | 153 | 7 | SM01381 | |
| Domain | ABC_tran | 4.45e-05 | 48 | 153 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.45e-05 | 48 | 153 | 5 | PS50893 | |
| Domain | DHHC | 4.79e-05 | 25 | 153 | 4 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 4.79e-05 | 25 | 153 | 4 | IPR001594 | |
| Domain | ABC_TRANSPORTER_1 | 4.93e-05 | 49 | 153 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 5.44e-05 | 50 | 153 | 5 | IPR003439 | |
| Domain | Alg10 | 6.67e-05 | 2 | 153 | 2 | IPR016900 | |
| Domain | GHS-R | 6.67e-05 | 2 | 153 | 2 | IPR003905 | |
| Domain | NPY4_rcpt | 6.67e-05 | 2 | 153 | 2 | IPR001933 | |
| Domain | DIE2_ALG10 | 6.67e-05 | 2 | 153 | 2 | PF04922 | |
| Domain | ABC_A | 1.12e-04 | 12 | 153 | 3 | IPR026082 | |
| Domain | GPCR_2-like | 1.31e-04 | 60 | 153 | 5 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.42e-04 | 61 | 153 | 5 | PS50261 | |
| Domain | ABC_transporter_CS | 3.80e-04 | 42 | 153 | 4 | IPR017871 | |
| Domain | GPR40-rel_orph | 3.96e-04 | 4 | 153 | 2 | IPR013312 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.02e-04 | 18 | 153 | 3 | PS00754 | |
| Domain | SNF | 4.74e-04 | 19 | 153 | 3 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.74e-04 | 19 | 153 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.74e-04 | 19 | 153 | 3 | PS50267 | |
| Domain | Na/ntran_symport | 4.74e-04 | 19 | 153 | 3 | IPR000175 | |
| Domain | Neurotransmitter_ion_chnl_CS | 4.97e-04 | 45 | 153 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 5.41e-04 | 46 | 153 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 5.87e-04 | 47 | 153 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 5.87e-04 | 47 | 153 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 5.87e-04 | 47 | 153 | 4 | IPR006029 | |
| Domain | - | 5.87e-04 | 47 | 153 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 5.87e-04 | 47 | 153 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 5.87e-04 | 47 | 153 | 4 | IPR006202 | |
| Domain | Na/ntran_symport_orphan | 6.56e-04 | 5 | 153 | 2 | IPR002438 | |
| Domain | TLV_coat | 1.36e-03 | 7 | 153 | 2 | PF00429 | |
| Domain | GPCR_2_secretin-like | 1.48e-03 | 60 | 153 | 4 | IPR000832 | |
| Domain | TLV/ENV_coat_polyprotein | 1.81e-03 | 8 | 153 | 2 | IPR018154 | |
| Domain | Retinal_BS | 1.81e-03 | 8 | 153 | 2 | IPR027430 | |
| Domain | NPY_rcpt | 2.31e-03 | 9 | 153 | 2 | IPR000611 | |
| Domain | OPSIN | 2.87e-03 | 10 | 153 | 2 | PS00238 | |
| Domain | Opsin | 3.49e-03 | 11 | 153 | 2 | IPR001760 | |
| Domain | Sugar/inositol_transpt | 5.69e-03 | 14 | 153 | 2 | IPR003663 | |
| Domain | 2pore_dom_K_chnl | 6.53e-03 | 15 | 153 | 2 | IPR003280 | |
| Domain | AAA+_ATPase | 6.68e-03 | 144 | 153 | 5 | IPR003593 | |
| Domain | AAA | 6.68e-03 | 144 | 153 | 5 | SM00382 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 2.52e-19 | 417 | 125 | 30 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR6B1 OR11L1 ABCA4 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 SLC26A5 OR4Q3 OR1A2 OR2M5 OR8U3 GRM1 OPN1SW OR1L3 OR6K6 OR10G7 CASK OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 8.58e-19 | 636 | 125 | 35 | M41834 |
| Pathway | WP_GPCRS_NONODORANT | CYSLTR2 GPR15 GALR1 LPAR4 HTR5A GPER1 FFAR3 GPR42 GRM1 SSTR2 F2R FZD1 FZD7 GHSR FZD8 NPY4R FZD5 GPR68 AGTR2 APLNR OPN5 CCR6 FZD2 HCRTR1 | 8.67e-18 | 266 | 125 | 24 | MM15843 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | OR6B1 CYSLTR2 GPR15 GALR1 LPAR4 HTR5A GPER1 MLNR FFAR3 GPR42 OR1A2 SSTR2 OPN1SW F2R OR12D3 GHSR OR11A1 NPY4R GPR68 AGTR2 APLNR CCR6 HCRTR1 | 6.98e-17 | 260 | 125 | 23 | M39397 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR12D3 OR51E1 OR11A1 OR4A5 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 OR52B6 | 5.20e-16 | 389 | 125 | 26 | M14091 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CYSLTR2 OXER1 GALR1 LPAR4 HTR5A GPER1 MLNR FFAR3 MCHR2 GRM1 SSTR2 OPN1SW F2R FZD1 FZD7 GHSR FZD8 NPY4R FZD5 GPR68 AGTR2 APLNR OPN5 CCR6 FZD2 HCRTR1 | 3.31e-14 | 463 | 125 | 26 | M507 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | CHRNA6 CYSLTR2 GALR1 LPAR4 HTR5A MLNR MCHR2 P2RY8 GRM1 SSTR2 F2R CHRNA1 LEPR CHRNA5 CHRNB3 GHSR NPY4R AGTR2 APLNR HCRTR1 | 2.97e-13 | 272 | 125 | 20 | M13380 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CYSLTR2 OXER1 GALR1 LPAR4 HTR5A GPER1 MLNR FFAR3 MCHR2 SSTR2 OPN1SW F2R GHSR NPY4R GPR68 AGTR2 APLNR OPN5 CCR6 HCRTR1 | 1.06e-11 | 330 | 125 | 20 | M18334 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CYSLTR2 OXER1 GPR15 GALR1 LPAR4 HTR5A GPER1 MLNR FFAR3 MCHR2 GRM1 SSTR2 OPN1SW F2R ADCY2 FZD1 FZD7 GHSR FZD8 NPY4R FZD5 GPR68 AGTR2 APLNR OPN5 CCR6 FZD2 HCRTR1 | 1.28e-11 | 702 | 125 | 28 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CYSLTR2 GALR1 LPAR4 HTR5A GPER1 FFAR3 GPR42 SSTR2 OPN1SW F2R NPY4R GPR68 AGTR2 APLNR OPN5 CCR6 HCRTR1 | 5.85e-09 | 333 | 125 | 17 | MM14963 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CYSLTR2 GALR1 LPAR4 HTR5A GPER1 FFAR3 GPR42 GRM1 SSTR2 OPN1SW F2R NPY4R GPR68 AGTR2 APLNR OPN5 CCR6 HCRTR1 | 4.37e-08 | 430 | 125 | 18 | MM15160 |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 9.50e-08 | 14 | 125 | 5 | M47834 | |
| Pathway | WP_GPCRS_OTHER | 1.72e-07 | 96 | 125 | 9 | MM15939 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | GALR1 GPER1 MLNR MCHR2 SSTR2 F2R GHSR NPY4R AGTR2 APLNR CCR6 HCRTR1 | 1.76e-07 | 197 | 125 | 12 | M12289 |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 2.04e-07 | 16 | 125 | 5 | M47823 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CYSLTR2 GPR15 GALR1 LPAR4 HTR5A GPER1 FFAR3 GPR42 GRM1 SSTR2 OPN1SW F2R ADCY2 GHSR NPY4R GPR68 AGTR2 APLNR OPN5 CCR6 HCRTR1 | 2.23e-07 | 646 | 125 | 21 | MM14962 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 ABCA4 SLC2A9 OSTM1 SLCO2B1 BEST2 TRPC4 SLC22A11 STEAP4 SLC34A2 SLC6A15 ATP10B ADCY2 ABCC6 SLC22A12 ESYT3 SLC6A13 SLC30A5 ABCA6 ABCA5 NIPAL2 SLC29A4 | 4.66e-07 | 736 | 125 | 22 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 5.32e-07 | 19 | 125 | 5 | M47833 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.17e-07 | 9 | 125 | 4 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.17e-07 | 9 | 125 | 4 | MM15313 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GALR1 HTR5A GPER1 GPR33 SSTR2 OPN1SW F2R NPY4R AGTR2 APLNR CCR6 | 7.89e-07 | 186 | 125 | 11 | MM15994 |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.85e-06 | 11 | 125 | 4 | M883 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 ABCA4 SLC2A9 OSTM1 SLCO2B1 BEST2 TRPC4 STEAP4 SLC34A2 SLC6A15 ATP10B ABCC6 SLC22A12 ESYT3 SLC6A13 SLC30A5 ABCA6 ABCA5 NIPAL2 SLC29A4 | 2.18e-06 | 681 | 125 | 20 | MM14985 |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.76e-06 | 12 | 125 | 4 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.76e-06 | 12 | 125 | 4 | MM15312 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 4.22e-06 | 28 | 125 | 5 | M77 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | OXER1 GALR1 HTR5A GPER1 MCHR2 SSTR2 OPN1SW ADCY2 NPY4R AGTR2 APLNR OPN5 CCR6 | 4.24e-06 | 314 | 125 | 13 | M600 |
| Pathway | WP_PEPTIDE_GPCRS | 4.38e-06 | 75 | 125 | 7 | M39696 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 5.51e-06 | 14 | 125 | 4 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 7.46e-06 | 15 | 125 | 4 | MM14704 | |
| Pathway | WP_GPCRS_ODORANT | OR7E24 GPR26 GPR33 GPR141 GPR135 GPR101 OPN1SW GPR179 OR10D3 | 1.07e-05 | 157 | 125 | 9 | MM15872 |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.53e-05 | 36 | 125 | 5 | M39699 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.31e-05 | 217 | 125 | 10 | M18437 | |
| Pathway | WP_GPCRS_PEPTIDE | 3.55e-05 | 70 | 125 | 6 | MM15959 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.55e-05 | 70 | 125 | 6 | MM14984 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.16e-05 | 44 | 125 | 5 | M11911 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.16e-05 | 44 | 125 | 5 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 4.65e-05 | 45 | 125 | 5 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 5.18e-05 | 46 | 125 | 5 | M47409 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GALR1 HTR5A GPER1 SSTR2 OPN1SW ADCY2 NPY4R AGTR2 APLNR OPN5 CCR6 | 5.20e-05 | 289 | 125 | 11 | MM15057 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 6.41e-05 | 197 | 125 | 9 | MM14970 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC2A9 SLCO2B1 SLC22A11 SLC34A2 SLC6A15 SLC22A12 SLC6A13 SLC30A5 SLC29A4 | 7.39e-05 | 249 | 125 | 10 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 9.96e-05 | 84 | 125 | 6 | M27334 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.05e-04 | 210 | 125 | 9 | MM15043 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 1.06e-04 | 85 | 125 | 6 | M48315 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 1.23e-04 | 55 | 125 | 5 | M17807 | |
| Pathway | WP_GPCRS_OTHER | 1.75e-04 | 93 | 125 | 6 | M39629 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 1.87e-04 | 60 | 125 | 5 | MM15150 | |
| Pathway | WP_WNT_SIGNALING | 2.02e-04 | 61 | 125 | 5 | MM15893 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 2.54e-04 | 64 | 125 | 5 | M27396 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC2A9 SLCO2B1 SLC34A2 SLC6A15 SLC22A12 SLC6A13 SLC30A5 SLC29A4 | 2.68e-04 | 238 | 125 | 9 | MM15076 |
| Pathway | KEGG_MELANOGENESIS | 2.75e-04 | 101 | 125 | 6 | M7761 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.88e-04 | 190 | 125 | 8 | MM15687 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 2.93e-04 | 66 | 125 | 5 | M39642 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 4.23e-04 | 17 | 125 | 3 | M39525 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.65e-04 | 76 | 125 | 5 | MM15072 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 5.94e-04 | 19 | 125 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 5.94e-04 | 19 | 125 | 3 | MM15107 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORT | 7.67e-04 | 5 | 125 | 2 | M27469 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CHRNA6 GRM1 ADCY2 CHRNA1 CHRNA5 CHRNB3 CASK KCNK18 SLC6A13 KCNK10 | 7.95e-04 | 335 | 125 | 10 | MM14503 |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 8.05e-04 | 21 | 125 | 3 | M39343 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 9.42e-04 | 85 | 125 | 5 | MM15041 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.16e-03 | 89 | 125 | 5 | M39563 | |
| Pathway | WNT_SIGNALING | 1.16e-03 | 89 | 125 | 5 | M5493 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 1.34e-03 | 92 | 125 | 5 | M27322 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.48e-03 | 94 | 125 | 5 | M797 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.78e-03 | 98 | 125 | 5 | M39731 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 2.03e-03 | 101 | 125 | 5 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 2.03e-03 | 101 | 125 | 5 | M39387 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 2.11e-03 | 8 | 125 | 2 | M27433 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.55e-03 | 31 | 125 | 3 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.55e-03 | 31 | 125 | 3 | MM15154 | |
| Pathway | REACTOME_OPSINS | 2.70e-03 | 9 | 125 | 2 | M6285 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.74e-03 | 211 | 125 | 7 | MM14502 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 2.80e-03 | 32 | 125 | 3 | M23 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 2.95e-03 | 110 | 125 | 5 | MM15977 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 3.31e-03 | 113 | 125 | 5 | M39669 | |
| Pathway | REACTOME_OPSINS | 3.35e-03 | 10 | 125 | 2 | MM15063 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CHRNA6 GRM1 ADCY2 CHRNA1 CHRNA5 CHRNB3 CASK KCNK18 SLC6A13 KCNK10 | 3.59e-03 | 411 | 125 | 10 | M735 |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 3.71e-03 | 116 | 125 | 5 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 3.84e-03 | 117 | 125 | 5 | M39530 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.99e-03 | 118 | 125 | 5 | M39852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 4.07e-03 | 11 | 125 | 2 | M47614 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 4.07e-03 | 11 | 125 | 2 | MM14547 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.75e-03 | 123 | 125 | 5 | MM14988 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 4.86e-03 | 12 | 125 | 2 | M1071 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 4.86e-03 | 12 | 125 | 2 | MM15163 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 5.71e-03 | 13 | 125 | 2 | M27415 | |
| Pathway | REACTOME_RETINOID_CYCLE_DISEASE_EVENTS | 5.71e-03 | 13 | 125 | 2 | M29612 | |
| Pubmed | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 | 6.61e-27 | 343 | 158 | 28 | 32295537 | |
| Pubmed | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 | 8.43e-27 | 346 | 158 | 28 | 14611657 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 | 1.21e-25 | 340 | 158 | 27 | 11875048 |
| Pubmed | OR6B1 OR11L1 OR7E24 OR2M7 OR2L3 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR51B2 | 1.21e-25 | 340 | 158 | 27 | 11802173 | |
| Pubmed | OR6B1 OR11L1 OR7E24 OR2M7 OR5B2 OR1S1 OR1S2 OR4E2 OR4Q3 OR1A2 OR2M5 OR8U3 OR1L3 OR6K6 OR10G7 OR52E2 OR10D3 OR12D3 OR51E1 OR4A8 OR11A1 OR4A5 OR1P1 OR52W1 OR51G1 OR10G8 OR8D4 OR52B6 | 1.70e-21 | 541 | 158 | 28 | 14983052 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.03e-10 | 79 | 158 | 9 | 12679517 | |
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 4.49e-10 | 10 | 158 | 5 | 15245425 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 4.49e-10 | 10 | 158 | 5 | 17532316 | |
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 8.21e-10 | 11 | 158 | 5 | 24860427 | |
| Pubmed | Molecular determinants of WNT9b responsiveness in nephron progenitor cells. | 8.21e-10 | 11 | 158 | 5 | 30978219 | |
| Pubmed | 8.21e-10 | 11 | 158 | 5 | 17576136 | ||
| Pubmed | 8.21e-10 | 11 | 158 | 5 | 17582687 | ||
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 1.08e-08 | 17 | 158 | 5 | 28733458 | |
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 1.32e-08 | 95 | 158 | 8 | 16754659 | |
| Pubmed | 1.42e-08 | 7 | 158 | 4 | 15370539 | ||
| Pubmed | 1.96e-08 | 38 | 158 | 6 | 22908908 | ||
| Pubmed | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. | 2.01e-08 | 19 | 158 | 5 | 21623369 | |
| Pubmed | Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis. | 2.83e-08 | 8 | 158 | 4 | 10559494 | |
| Pubmed | 4.49e-08 | 22 | 158 | 5 | 17064353 | ||
| Pubmed | A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. | 5.08e-08 | 9 | 158 | 4 | 9707618 | |
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 8.96e-08 | 25 | 158 | 5 | 12812787 | |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 9813155 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 24303013 | ||
| Pubmed | Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. | 9.20e-08 | 3 | 158 | 3 | 27680706 | |
| Pubmed | OSTM1 SLC38A9 SLC34A2 PRSS23 GDPD5 SPPL2A SCAP TM2D2 APLNR LEPROTL1 SLC25A19 RNF145 MFSD5 | 9.63e-08 | 430 | 158 | 13 | 16303743 | |
| Pubmed | 1.44e-07 | 179 | 158 | 9 | 18577758 | ||
| Pubmed | 1.97e-07 | 29 | 158 | 5 | 18364260 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 20854418 | ||
| Pubmed | Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. | 3.67e-07 | 4 | 158 | 3 | 22396410 | |
| Pubmed | 3.68e-07 | 200 | 158 | 9 | 18240029 | ||
| Pubmed | 3.96e-07 | 14 | 158 | 4 | 19059502 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 5.38e-07 | 15 | 158 | 4 | 8838678 | |
| Pubmed | 6.11e-07 | 36 | 158 | 5 | 24151333 | ||
| Pubmed | 7.04e-07 | 37 | 158 | 5 | 15342465 | ||
| Pubmed | Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. | 7.04e-07 | 37 | 158 | 5 | 18800919 | |
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 19259974 | ||
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 23034182 | ||
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 8.08e-07 | 38 | 158 | 5 | 21041481 | |
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 8.08e-07 | 38 | 158 | 5 | 18635608 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 19543507 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 27481942 | ||
| Pubmed | 1.24e-06 | 75 | 158 | 6 | 2834384 | ||
| Pubmed | CHRNA6 GALR1 HTR5A SSTR2 CHRNA1 LEPR CHRNA5 CHRNB3 SLC6A13 HCRTR1 | 1.28e-06 | 300 | 158 | 10 | 19086053 | |
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 1.51e-06 | 19 | 158 | 4 | 17373692 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 36867021 | ||
| Pubmed | Regulation of RAS palmitoyltransferases by accessory proteins and palmitoylation. | 1.82e-06 | 6 | 158 | 3 | 38182928 | |
| Pubmed | Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins. | 1.82e-06 | 6 | 158 | 3 | 32514064 | |
| Pubmed | 1.88e-06 | 20 | 158 | 4 | 16647879 | ||
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 2.39e-06 | 47 | 158 | 5 | 28813421 | |
| Pubmed | 2.39e-06 | 47 | 158 | 5 | 33141892 | ||
| Pubmed | 2.39e-06 | 47 | 158 | 5 | 18351675 | ||
| Pubmed | 2.81e-06 | 22 | 158 | 4 | 8894702 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 2.95e-06 | 49 | 158 | 5 | 19562671 | |
| Pubmed | Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. | 3.18e-06 | 7 | 158 | 3 | 9192640 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 15195140 | ||
| Pubmed | Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. | 3.18e-06 | 7 | 158 | 3 | 11265645 | |
| Pubmed | 3.26e-06 | 50 | 158 | 5 | 27510977 | ||
| Pubmed | 4.06e-06 | 24 | 158 | 4 | 9096311 | ||
| Pubmed | 4.06e-06 | 24 | 158 | 4 | 8626800 | ||
| Pubmed | Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. | 5.07e-06 | 8 | 158 | 3 | 14623098 | |
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 19388021 | ||
| Pubmed | 6.14e-06 | 212 | 158 | 8 | 19521566 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 26122848 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 8906617 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 19228980 | ||
| Pubmed | Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95. | 7.57e-06 | 9 | 158 | 3 | 12067714 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 23095888 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 7.79e-06 | 219 | 158 | 8 | 12213199 | |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 1.08e-05 | 10 | 158 | 3 | 11435397 | |
| Pubmed | 1.08e-05 | 10 | 158 | 3 | 19503597 | ||
| Pubmed | 1.08e-05 | 10 | 158 | 3 | 20736995 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 12225896 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 19890391 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.73e-05 | 118 | 158 | 6 | 19156168 | |
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 1.92e-05 | 35 | 158 | 4 | 16939646 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 20584212 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25637492 | ||
| Pubmed | Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits. | 2.05e-05 | 2 | 158 | 2 | 22315221 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30478340 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25823894 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31131560 | ||
| Pubmed | Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. | 2.05e-05 | 2 | 158 | 2 | 20034618 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33091847 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18055561 | ||
| Pubmed | Intestinal FFA3 mediates obesogenic effects in mice on a Western diet. | 2.05e-05 | 2 | 158 | 2 | 35858247 | |
| Pubmed | Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP. | 2.05e-05 | 2 | 158 | 2 | 29068315 | |
| Pubmed | Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice. | 2.05e-05 | 2 | 158 | 2 | 22391948 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22506074 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28851948 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24107611 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24748202 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36362376 | ||
| Pubmed | Protein expression of urate transporters in renal tissue of patients with uric acid nephrolithiasis. | 2.05e-05 | 2 | 158 | 2 | 24723238 | |
| Pubmed | Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis. | 2.05e-05 | 2 | 158 | 2 | 19401193 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 20399779 | ||
| Pubmed | Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. | 2.05e-05 | 2 | 158 | 2 | 29748286 | |
| Pubmed | Functional implications of limited leptin receptor and ghrelin receptor coexpression in the brain. | 2.05e-05 | 2 | 158 | 2 | 21674492 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18704094 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 11342119 | ||
| Pubmed | URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia. | 2.05e-05 | 2 | 158 | 2 | 29486147 | |
| Interaction | ATP2B2 interactions | 8.47e-07 | 198 | 134 | 10 | int:ATP2B2 | |
| Interaction | RTP2 interactions | 2.15e-06 | 89 | 134 | 7 | int:RTP2 | |
| Interaction | SIDT2 interactions | 4.43e-06 | 140 | 134 | 8 | int:SIDT2 | |
| Interaction | UPK1A interactions | 7.38e-06 | 150 | 134 | 8 | int:UPK1A | |
| Interaction | TSPAN15 interactions | ZDHHC18 PCNX3 ERMP1 FZD8 SCAP ZDHHC9 ALG10 TMEM192 CCR6 FZD2 | 1.62e-05 | 276 | 134 | 10 | int:TSPAN15 |
| Interaction | OR1D4 interactions | 2.49e-05 | 26 | 134 | 4 | int:OR1D4 | |
| Interaction | TAP1 interactions | 3.05e-05 | 133 | 134 | 7 | int:TAP1 | |
| Interaction | ACAD10 interactions | 6.17e-05 | 102 | 134 | 6 | int:ACAD10 | |
| Interaction | LRRC55 interactions | 7.78e-05 | 66 | 134 | 5 | int:LRRC55 | |
| Interaction | SCGB1C1 interactions | 7.83e-05 | 13 | 134 | 3 | int:SCGB1C1 | |
| Interaction | SLC41A1 interactions | 1.42e-04 | 40 | 134 | 4 | int:SLC41A1 | |
| Interaction | TTYH1 interactions | 1.83e-04 | 300 | 134 | 9 | int:TTYH1 | |
| Interaction | GPR21 interactions | 2.06e-04 | 81 | 134 | 5 | int:GPR21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.98e-04 | 345 | 157 | 7 | chr11q12 | |
| GeneFamily | Solute carriers | SLC6A18 SLC2A9 SLC38A9 SLCO2B1 SLC22A11 SLC26A5 SLC34A2 SLC6A15 SLC22A24 SLC22A12 SLC2A5 SLC6A13 SLC46A3 SLC10A1 SLC30A5 SLC16A6 SLC22A10 SLC25A19 SLC38A6 SLC29A4 SLC4A11 | 5.73e-13 | 395 | 128 | 21 | 752 |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 7.34e-09 | 11 | 128 | 5 | 286 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 7.84e-08 | 78 | 128 | 8 | 262 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 4.08e-06 | 16 | 128 | 4 | 173 | |
| GeneFamily | Olfactory receptors, family 1 | 8.87e-06 | 40 | 128 | 5 | 147 | |
| GeneFamily | Peptide receptors | 1.19e-05 | 7 | 128 | 3 | 220 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 2.28e-05 | 24 | 128 | 4 | 76 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 4.97e-05 | 2 | 128 | 2 | 448 | |
| GeneFamily | ATP binding cassette subfamily A | 1.19e-04 | 14 | 128 | 3 | 805 | |
| GeneFamily | Leukotriene receptors | 7.32e-04 | 6 | 128 | 2 | 204 | |
| GeneFamily | Opsin receptors | 2.62e-03 | 11 | 128 | 2 | 215 | |
| GeneFamily | ATP binding cassette subfamily C | 3.69e-03 | 13 | 128 | 2 | 807 | |
| GeneFamily | Olfactory receptors, family 51 | 3.71e-03 | 44 | 128 | 3 | 164 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 4.92e-03 | 15 | 128 | 2 | 277 | |
| GeneFamily | Olfactory receptors, family 52 | 5.04e-03 | 49 | 128 | 3 | 165 | |
| GeneFamily | Olfactory receptors, family 11 | 1.14e-02 | 23 | 128 | 2 | 159 | |
| GeneFamily | Olfactory receptors, family 10 | 1.15e-02 | 66 | 128 | 3 | 157 | |
| GeneFamily | Olfactory receptors, family 4 | 1.34e-02 | 129 | 128 | 4 | 151 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 PNPLA3 | 1.41e-08 | 177 | 157 | 9 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 PNPLA3 | 1.80e-08 | 182 | 157 | 9 | e1e58176f533092b6b974ca1ce8b02192a6e193d |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 PNPLA3 | 1.80e-08 | 182 | 157 | 9 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC22A24 SLC22A12 SLC6A13 MAST4 KCNK10 PNPLA3 | 1.98e-08 | 184 | 157 | 9 | 9434731f651820b05335085582960f08fbf895de |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC34A2 SLC22A24 ADCY2 SLC22A12 SLC6A13 MAST4 | 2.17e-08 | 186 | 157 | 9 | b1edc341d6684b347dc9e21b34f62f51d095d735 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A24 ABCC6 SLC22A12 SLC2A5 SLC6A13 KCNK10 | 2.17e-07 | 176 | 157 | 8 | 1595dbeee336a81e581325d63208ec6262664ee9 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 MAST4 | 2.47e-07 | 179 | 157 | 8 | d1ef7e1cb00336118e387b47f4f8120f53584391 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 MAST4 PNPLA3 | 2.69e-07 | 181 | 157 | 8 | 9542c19edc9bd2cba68c01c2a8407705398e3011 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 MAST4 PNPLA3 | 2.69e-07 | 181 | 157 | 8 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SLC6A18 SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 | 2.81e-07 | 182 | 157 | 8 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 PNPLA3 | 3.31e-07 | 186 | 157 | 8 | a417e1e21313a7e05951038cdef5ac672a9f727c |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 PNPLA3 | 3.45e-07 | 187 | 157 | 8 | 1b82920588f9e26ef1db244d452736d75fcfd342 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SLC2A9 SLC22A11 SLC22A24 ABCC6 SLC22A12 SLC6A13 KCNK10 PNPLA3 | 3.45e-07 | 187 | 157 | 8 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 183 | 157 | 7 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 183 | 157 | 7 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 183 | 157 | 7 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 188 | 157 | 7 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 188 | 157 | 7 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-06 | 189 | 157 | 7 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-06 | 189 | 157 | 7 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.98e-06 | 123 | 157 | 6 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.68e-06 | 193 | 157 | 7 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.07e-06 | 195 | 157 | 7 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 195 | 157 | 7 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 196 | 157 | 7 | 83aeb96a33802949238d8a097086a1812201d1b5 | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 6.93e-06 | 199 | 157 | 7 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 2.31e-05 | 161 | 157 | 6 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 2.31e-05 | 161 | 157 | 6 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 162 | 157 | 6 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 164 | 157 | 6 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 164 | 157 | 6 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 164 | 157 | 6 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 164 | 157 | 6 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.75e-05 | 166 | 157 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 169 | 157 | 6 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 170 | 157 | 6 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 170 | 157 | 6 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 171 | 157 | 6 | fd59ac4a39748840b2ee1c930ea475433ff61485 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 171 | 157 | 6 | d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 171 | 157 | 6 | d382430e5cdd0f2aac4fc093d8fe8d66efb4629b | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 171 | 157 | 6 | 4347e6f62c04ea43299893ad4b79719049009a56 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 177 | 157 | 6 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.06e-05 | 178 | 157 | 6 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 179 | 157 | 6 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 179 | 157 | 6 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 4.60e-05 | 182 | 157 | 6 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.60e-05 | 182 | 157 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.74e-05 | 183 | 157 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 4.88e-05 | 184 | 157 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-05 | 184 | 157 | 6 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.88e-05 | 184 | 157 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 4.88e-05 | 184 | 157 | 6 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.19e-05 | 186 | 157 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.19e-05 | 186 | 157 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-05 | 186 | 157 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-05 | 189 | 157 | 6 | da014519d6eb21bc2dc2ed65eafe638b42a068ed | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-05 | 190 | 157 | 6 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.83e-05 | 190 | 157 | 6 | 0a944da2aaaef9289b2a4ffe360b0338724fd59b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 157 | 6 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 157 | 6 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 157 | 6 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 157 | 6 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.74e-05 | 195 | 157 | 6 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.74e-05 | 195 | 157 | 6 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 157 | 6 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.80e-05 | 62 | 157 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.80e-05 | 62 | 157 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 196 | 157 | 6 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 196 | 157 | 6 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 6.93e-05 | 196 | 157 | 6 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 196 | 157 | 6 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-05 | 197 | 157 | 6 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-05 | 197 | 157 | 6 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-05 | 197 | 157 | 6 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.24e-05 | 122 | 157 | 5 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.33e-05 | 198 | 157 | 6 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | moderate-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.33e-05 | 198 | 157 | 6 | 7ecce5e266bb08797088cc8f8309e0c7b48df5c9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.53e-05 | 199 | 157 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.75e-05 | 200 | 157 | 6 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.75e-05 | 200 | 157 | 6 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.75e-05 | 200 | 157 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.75e-05 | 200 | 157 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.75e-05 | 200 | 157 | 6 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.75e-05 | 200 | 157 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.43e-05 | 129 | 157 | 5 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | Goblet-gob-2|World / Class top | 1.48e-04 | 142 | 157 | 5 | 9b058dc313d1f0edcd8473e342852632e17536a6 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 76 | 157 | 4 | f653a09d6707d9b34db4ef486212aeba5610f47b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 76 | 157 | 4 | 47deea63d975366a42834c22cc163c4c7142d51d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 76 | 157 | 4 | 079e1af894e670f63d718e16599f20d920643160 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Nonmucinous_Lepidic_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.53e-04 | 143 | 157 | 5 | 510e0410544f78ebc5bb597e87f01a00ce48b39b | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 77 | 157 | 4 | 7bb18406d404c51ee938cc577c155dc51868ddb9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 77 | 157 | 4 | ac311740424ff75b478b3c19fa0fae93776eb54e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 77 | 157 | 4 | 9f2dbf922acb905d636427a766a217c0db9671d2 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 1.97e-04 | 151 | 157 | 5 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-04 | 155 | 157 | 5 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-04 | 155 | 157 | 5 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-04 | 155 | 157 | 5 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-04 | 156 | 157 | 5 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 157 | 157 | 5 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 157 | 157 | 5 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| Drug | BAPTA | CHRNA6 HTR5A TRPC4 GRM1 F2R CHRNA1 CHRNB3 SLC6A13 GPR68 AGTR2 DSE | 8.67e-06 | 324 | 147 | 11 | CID000104751 |
| Drug | verapamil | CHRNA6 ABCA4 MLNR ADCY2 CHRNA1 ABCC6 CHRNB3 KCNK18 ABCA6 ABCA5 SCN7A KCNK10 ABCC12 | 1.84e-05 | 490 | 147 | 13 | CID000002520 |
| Drug | sulfinpyrazone | 2.15e-05 | 87 | 147 | 6 | CID000005342 | |
| Drug | pozanicline | 2.15e-05 | 9 | 147 | 3 | ctd:C108326 | |
| Drug | pentolinium | 3.03e-05 | 28 | 147 | 4 | CID000005849 | |
| Drug | vecuronium | 4.01e-05 | 30 | 147 | 4 | CID000039764 | |
| Drug | 0JO | 4.14e-05 | 2 | 147 | 2 | CID015942668 | |
| Drug | Dns-C6-Cho | 4.19e-05 | 11 | 147 | 3 | CID000124728 | |
| Drug | AC1L9NC9 | 4.19e-05 | 11 | 147 | 3 | CID000449642 | |
| Drug | dihydronereistoxin | 4.19e-05 | 11 | 147 | 3 | CID000121232 | |
| Drug | LJP 1082 | 4.19e-05 | 11 | 147 | 3 | CID003037609 | |
| Drug | bipinnatin-B | 4.19e-05 | 11 | 147 | 3 | CID000127363 | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 3583_UP | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 5906_DN | |
| Drug | I Tax | 5.56e-05 | 12 | 147 | 3 | CID000003792 | |
| Drug | AC1L9P8C | 5.56e-05 | 12 | 147 | 3 | CID000450864 | |
| Drug | SureCN373116 | 5.56e-05 | 12 | 147 | 3 | CID010085732 | |
| Drug | succinylcholine | 5.88e-05 | 64 | 147 | 5 | CID000005314 | |
| Drug | nereistoxin | 7.19e-05 | 13 | 147 | 3 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 7.19e-05 | 13 | 147 | 3 | CID004392675 | |
| Drug | C-toxiferine-I | 7.19e-05 | 13 | 147 | 3 | CID005089093 | |
| Drug | bipinnatin-A | 7.19e-05 | 13 | 147 | 3 | CID000196603 | |
| Drug | bipinnatin-C | 7.19e-05 | 13 | 147 | 3 | CID000129977 | |
| Drug | gallamine | 7.47e-05 | 35 | 147 | 4 | CID000003450 | |
| Drug | atracurium | 7.47e-05 | 35 | 147 | 4 | CID000047319 | |
| Drug | 2-(aminomethyl)pyrrolidine | 8.63e-05 | 161 | 147 | 7 | CID000072032 | |
| Drug | A 172 | 9.05e-05 | 70 | 147 | 5 | CID000014025 | |
| Drug | 2,3-dichlorooctafluorobutane | 9.11e-05 | 14 | 147 | 3 | CID000078982 | |
| Drug | LNF 209 | 9.11e-05 | 14 | 147 | 3 | CID000132666 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 9.33e-05 | 37 | 147 | 4 | CID000009643 | |
| Drug | phenoxybenzamine | 1.03e-04 | 115 | 147 | 6 | CID000004768 | |
| Drug | NSC-293162 | 1.04e-04 | 38 | 147 | 4 | CID000004675 | |
| Drug | anatoxin-a hydrochloride | 1.13e-04 | 15 | 147 | 3 | CID000135265 | |
| Drug | SAD-128 | 1.13e-04 | 15 | 147 | 3 | CID000162008 | |
| Drug | N-methylcytisine | 1.13e-04 | 15 | 147 | 3 | CID000234566 | |
| Drug | aa373 | 1.13e-04 | 15 | 147 | 3 | CID000191672 | |
| Drug | (-)-pictamine | 1.13e-04 | 15 | 147 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 1.13e-04 | 15 | 147 | 3 | CID006918624 | |
| Drug | UB-165 | 1.13e-04 | 15 | 147 | 3 | CID004694339 | |
| Drug | methylatropine | 1.27e-04 | 40 | 147 | 4 | CID000005860 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 1.39e-04 | 16 | 147 | 3 | CID000123866 | |
| Drug | AC1L2SVN | 1.39e-04 | 16 | 147 | 3 | CID000127922 | |
| Drug | benzoquinonium | 1.39e-04 | 16 | 147 | 3 | CID000009393 | |
| Drug | PNU-282,987 | 1.39e-04 | 16 | 147 | 3 | CID004655349 | |
| Drug | probenecid | 1.49e-04 | 123 | 147 | 6 | CID000004911 | |
| Drug | AC1L1BQX | 1.61e-04 | 79 | 147 | 5 | CID000001565 | |
| Drug | oxymetazoline | 1.61e-04 | 79 | 147 | 5 | CID000004636 | |
| Drug | cimetidine | 1.67e-04 | 179 | 147 | 7 | CID000002756 | |
| Drug | Nsc36388 | 1.68e-04 | 17 | 147 | 3 | CID000014954 | |
| Drug | gallamin | 1.69e-04 | 43 | 147 | 4 | CID000067425 | |
| Drug | bupropion | 1.81e-04 | 81 | 147 | 5 | CID000000444 | |
| Drug | AC1O8PVM | 2.00e-04 | 18 | 147 | 3 | CID000004989 | |
| Drug | ABT-594 | 2.00e-04 | 18 | 147 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 2.00e-04 | 18 | 147 | 3 | CID000656712 | |
| Drug | benzetimide | 2.00e-04 | 18 | 147 | 3 | CID000021846 | |
| Drug | 3H-diazirine | 2.02e-04 | 45 | 147 | 4 | CID000078958 | |
| Drug | Ino-Hcy | 2.03e-04 | 83 | 147 | 5 | CID000193585 | |
| Drug | halothane | 2.10e-04 | 314 | 147 | 9 | CID000003562 | |
| Drug | metoclopramide | 2.15e-04 | 84 | 147 | 5 | CID000004168 | |
| Drug | pilsicainide | 2.20e-04 | 46 | 147 | 4 | CID000004820 | |
| Drug | AC1L9P88 | 2.37e-04 | 19 | 147 | 3 | CID000450860 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 2.37e-04 | 19 | 147 | 3 | CID000162425 | |
| Drug | isoarecolone | 2.37e-04 | 19 | 147 | 3 | CID000146970 | |
| Drug | beta-erythroidine | 2.37e-04 | 19 | 147 | 3 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 2.37e-04 | 19 | 147 | 3 | CID000107881 | |
| Drug | PNU-120596 | 2.37e-04 | 19 | 147 | 3 | CID000311434 | |
| Drug | 3-isoreserpine | 2.40e-04 | 190 | 147 | 7 | CID000005052 | |
| Drug | glutaric acid | 2.46e-04 | 4 | 147 | 2 | ctd:C035736 | |
| Drug | Oxypurinol | 2.46e-04 | 4 | 147 | 2 | ctd:D010117 | |
| Drug | alpha-conotoxin MII | 2.46e-04 | 4 | 147 | 2 | ctd:C098872 | |
| Drug | myo-inositol | CHRNA6 GALR1 LPAR4 TRPC4 PRSS23 GRM1 F2R ADCY2 CHRNA1 CHRNB3 GHSR CEPT1 GPR68 ALG10 AGTR2 | 2.49e-04 | 811 | 147 | 15 | CID000000892 |
| Drug | epicholesterol | CHRNA6 ABCA4 HTR5A CH25H ADCY2 CHRNA1 CHRNB3 SCAP SLC10A1 ABCA6 ABCA5 DHCR7 PNPLA3 | 2.54e-04 | 636 | 147 | 13 | CID000000304 |
| Drug | Mirex | 2.60e-04 | 48 | 147 | 4 | ctd:D008917 | |
| Disease | Renal hypouricemia | 2.30e-05 | 2 | 142 | 2 | C0473219 | |
| Disease | Familial renal hypouricemia | 2.30e-05 | 2 | 142 | 2 | cv:C4551590 | |
| Disease | Hypouricemia, renal | 2.30e-05 | 2 | 142 | 2 | cv:CN377535 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 2.33e-05 | 12 | 142 | 3 | C1861063 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 5.84e-05 | 16 | 142 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Long Qt Syndrome 2 | 6.88e-05 | 3 | 142 | 2 | C3150943 | |
| Disease | gout, urate measurement | 6.88e-05 | 3 | 142 | 2 | EFO_0004274, EFO_0004531 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 3.41e-04 | 6 | 142 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | stromal cell-derived factor 1 measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0020756 | |
| Disease | uric acid measurement | SLC2A9 PCNX3 SLC22A11 AAK1 SLC22A24 SLC22A12 SLC10A1 ABCA6 SLC22A10 PNPLA3 | 7.68e-04 | 610 | 142 | 10 | EFO_0004761 |
| Disease | time to first cigarette measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0010126 | |
| Disease | estrogen measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0011007 | |
| Disease | hepatocellular carcinoma | 1.02e-03 | 41 | 142 | 3 | EFO_0000182 | |
| Disease | cocaine use | 1.23e-03 | 11 | 142 | 2 | C3496069 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | non-alcoholic steatohepatitis | 1.47e-03 | 12 | 142 | 2 | EFO_1001249 | |
| Disease | corpus callosum posterior volume measurement | 2.03e-03 | 52 | 142 | 3 | EFO_0010298 | |
| Disease | Withdrawal Symptoms | 2.77e-03 | 58 | 142 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.77e-03 | 58 | 142 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.77e-03 | 58 | 142 | 3 | C0038587 | |
| Disease | Age-related macular degeneration | 3.35e-03 | 18 | 142 | 2 | cv:C0242383 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 3.35e-03 | 18 | 142 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | IgA glomerulonephritis (is_marker_for) | 4.13e-03 | 20 | 142 | 2 | DOID:2986 (is_marker_for) | |
| Disease | nose morphology measurement, mouth morphology measurement | 4.55e-03 | 21 | 142 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Nystagmus | 4.55e-03 | 21 | 142 | 2 | HP_0000639 | |
| Disease | Cocaine Dependence | 4.64e-03 | 139 | 142 | 4 | C0600427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFCLIGYVPSVILFT | 1106 | Q8WWZ7 | |
| FVCKYLSIFAPFLTL | 206 | P49069 | |
| CTFVVRVLFYLGPVY | 36 | A0FGR9 | |
| YTLFLIIPCLGLSFL | 236 | Q05901 | |
| LCVPIFTLLQFFFYA | 271 | Q8NFU1 | |
| FLCTSVLPFYLGAEL | 1671 | Q96N23 | |
| RPFLVGLVVAICLFY | 16 | A4D0V7 | |
| GVIYFTLYLPHILCF | 766 | P78363 | |
| LLYKLCYFTLPFGES | 251 | Q2M2I8 | |
| IFTFFVPLLSIVTCY | 201 | P49685 | |
| LLGFLLPFFIIIFCY | 211 | Q49SQ1 | |
| GSFFLFLVLCSISPY | 1016 | Q8N139 | |
| DFLVCFIPYFQTLLF | 1196 | Q8N139 | |
| IIPLIFIATCYFGIR | 221 | P50052 | |
| RLFVPIAYSLICVFG | 46 | P51684 | |
| VILLLFLFGPCFFNL | 466 | B6SEH9 | |
| PYILLGFLFCAFVVV | 256 | Q5I7T1 | |
| ASVIFLLLFAPFIVY | 41 | Q9UBM7 | |
| ITFLLVCSGTFFPYS | 661 | Q7Z2K6 | |
| SLICFFIPYLAYKGS | 1206 | O94823 | |
| LVFPFIAISCSYGRV | 206 | Q8NG85 | |
| IGVILVCFLPYQFFR | 231 | Q7Z602 | |
| LFLIPFVITVACYTA | 201 | Q86VZ1 | |
| PCLLFSFLTGLVFYL | 241 | P02708 | |
| PFGTFFCKLSSYLIF | 96 | P35414 | |
| VCVILAFYTPALFSF | 246 | Q8NGJ4 | |
| AELQLPLFCLFLGIY | 21 | Q8NGM9 | |
| PLFCLFLGIYTVTVV | 26 | Q8NGM9 | |
| GVILFILLSGCLPFY | 206 | O14936 | |
| VFFVIFLCIYPITLT | 26 | Q9Y585 | |
| VVLCFFGPGLFIYLR | 246 | Q8NGN6 | |
| IFPFTLSFFSYVCII | 221 | Q8NH92 | |
| FCLTIPFGLILTSYA | 206 | Q9GZK7 | |
| FPGLCFLCFLVTYAL | 21 | Q7Z418 | |
| CVILAFYIPGLFSYL | 251 | Q6IF63 | |
| VIFGCLAFTFYILLL | 471 | Q8N468 | |
| TFLLLFQYCLPLGFI | 216 | P50391 | |
| RLILFIYLSCFFLPV | 21 | P61550 | |
| TVLFGFLLLYFPVFI | 421 | Q6PRD1 | |
| LLFVCTLPFKIFYNF | 86 | Q99677 | |
| VLFCLLFLYPGLADS | 6 | P06681 | |
| NLEIVLFFFPFYTCL | 246 | Q9Y3R5 | |
| YLHFLCYVTFILPAT | 6 | Q30KQ6 | |
| FIGTFLVCFAPYVIT | 246 | Q8NDV2 | |
| VGICIALFALPFVIY | 441 | P17181 | |
| VFTLCFPFVFLLGLL | 906 | Q9H6A9 | |
| IFFYVSLLGSECFLL | 101 | A3KFT3 | |
| IFFYISLLGSECFLL | 101 | Q8NG81 | |
| SIPFFAVYVCILLGN | 26 | Q9Y5P1 | |
| VCAVFIFYVPFIGLS | 246 | Q8TCB6 | |
| IPFCFIYLTVILGNL | 31 | Q8NGK1 | |
| VILLFYVPALFSVFA | 266 | Q8NGF0 | |
| IFVPCVFIYLRPFCS | 251 | Q8NH05 | |
| FILFTFIYLLTLCGN | 26 | Q96R09 | |
| ALVCSCFIPFYSGLI | 141 | Q9NST1 | |
| VLAPLFVYLFIGTSF | 416 | Q14332 | |
| FCLLLPTAVIVFSYV | 206 | Q6U736 | |
| LFVLFFYILSPIPYC | 36 | O95214 | |
| RGAPSVFFIYLLCFV | 6 | Q9UL01 | |
| YECIFQPIFLLSGYT | 496 | P48357 | |
| LCTFFTVVFALYLAP | 196 | Q8WTR4 | |
| KIFCILYAIFGIPLF | 181 | P57789 | |
| FSYVLSLGPYCFLAV | 406 | Q96P66 | |
| VVLCFFGPGLFIYLR | 246 | Q8NGN5 | |
| VLCICFFLTLGPYVF | 206 | Q8NGX0 | |
| FILFLPVVFYLSSFL | 291 | Q86WC4 | |
| FPDLLGRLLTTCLFY | 1561 | Q8NDA8 | |
| FVFSVYLLTFLVGLP | 16 | O15529 | |
| ILCPLSGFIFFTTIY | 86 | O15529 | |
| VAVYTICFLPSIIFG | 301 | Q8TDS5 | |
| IFPFVLIFFSYVCII | 221 | Q8NGQ3 | |
| LTLLSCFYVIGFLLF | 211 | Q9UGF7 | |
| AVFFFVPLIISTVCY | 276 | P25116 | |
| FIGFLLGYVLSALFC | 231 | Q14973 | |
| CFSSPSYLRIFFIIF | 676 | P26012 | |
| FFFPLPLILVCYILI | 206 | Q969V1 | |
| HSCFFIVTYLAPLGL | 216 | O43613 | |
| VLAPLFVYLFIGTSF | 491 | Q9UP38 | |
| GPALCTIVFLLVYFF | 311 | Q13467 | |
| LAPLFVYLFIGTSFL | 426 | O75084 | |
| RPIIFLSACYLFVSV | 311 | Q9H461 | |
| TGPALCTVVFLLVYF | 391 | Q9H461 | |
| VVCTFVFGYLLPLLL | 201 | P47211 | |
| HFYLVTPSLVFLCFI | 71 | P0CF75 | |
| CLFISFLTVLVFYLP | 251 | Q15825 | |
| LFYTLFLIIPCIGLS | 251 | P30532 | |
| CIGLSFLTVLVFYLP | 261 | P30532 | |
| FLPYFIYSCILGLIS | 736 | Q08462 | |
| PCLYILTFGFVSAKI | 316 | Q9Y6K0 | |
| AFSVGLVVACYLLPF | 276 | Q8IZ08 | |
| FFLPVFCLTVLYSLI | 221 | Q92847 | |
| FVFSVYLLTFLVGLP | 16 | O14843 | |
| ILCPLSGFIFFTTIY | 86 | O14843 | |
| LFAIGYFLQRIICPS | 91 | F5H4A9 | |
| VGAFYLPLCVVLFVY | 206 | P47898 | |
| FLCTVPGVYFLSLNV | 156 | P60827 | |
| IILYEFLVGCVPFFG | 771 | O15021 | |
| TICITGAIYLYFVLP | 486 | Q9NRM0 | |
| AGIFLGYVCPFTLIA | 636 | Q13255 | |
| PTFVIYCGLRFVAAF | 191 | Q9NSA0 | |
| LQLVVSVPFFLCFLY | 261 | Q96S37 | |
| GYFTLVPAIQEFCLF | 406 | Q12770 | |
| AACGLAFVFIYPSLI | 511 | Q8NBW4 | |
| VIFSITTYVGFCLPF | 41 | O95992 | |
| AFLLIELACGLYFPS | 346 | Q6N075 | |
| FFLPFLCLSILYGLI | 256 | O43193 | |
| TLFVLFLPFYACTLL | 26 | Q8NH80 | |
| FLPFYACTLLGNVSI | 31 | Q8NH80 | |
| PLYFFISVLSFLEIC | 86 | Q8NGW6 | |
| GLGYCFSFLPTVTIL | 126 | O15403 | |
| CVLLLAFPITFSYFH | 141 | Q8NH93 | |
| VLVVGFPANCLSLYF | 31 | Q15743 | |
| LVGFLFPICLLLASY | 191 | Q15743 | |
| VALFFGTVIRAYLCP | 261 | Q8NH06 | |
| IFCFIVPLSLICFSY | 206 | P03999 | |
| STVVVLFFVPCIFIY | 241 | Q8NH83 | |
| PFLGSPVYFFLACLS | 51 | P0C604 | |
| LYFACLLPTIAFGSL | 366 | Q8NBS3 | |
| FSSLFPYVVLICFLI | 256 | Q9H2J7 | |
| FFSVLIGLIPYNFIC | 186 | Q96HV5 | |
| AFAPTFLVYCILRFL | 191 | Q8N4F4 | |
| FGLCFVRFAITVPFY | 351 | Q8N4F4 | |
| FYLLPFIFSTGLCAL | 6 | A0A075B6K6 | |
| AVGTPLCLYALFLFL | 941 | O95255 | |
| CFSFHVIFVLYGAPL | 91 | Q07326 | |
| FPVYCVLRFLAGFSS | 196 | Q63ZE4 | |
| CRFGFVAIYLTEPLV | 196 | P58743 | |
| IYLFGCFLSFLGVFL | 311 | Q9H841 | |
| ILFFFFLKRCPSYTE | 6 | Q6IFN5 | |
| GLGPYSFIVFAVICL | 436 | P22732 | |
| LFFLLCAVGQVSPYS | 11 | O95084 | |
| VIGLFLSCLYTIFLF | 56 | Q99527 | |
| LSCLYTIFLFPIGFV | 61 | Q99527 | |
| LGFIVPFAIIGLCYS | 221 | Q99527 | |
| LCYFAFPFQLLIAST | 121 | Q7Z3Q1 | |
| STSTCLIFIFPGLFY | 401 | Q8IZM9 | |
| PCFGVFLVIYLVTVL | 26 | Q8NH85 | |
| CAAYAFFILGPTALI | 251 | Q96J65 | |
| IFLFPLFITVLSYGC | 206 | O95007 | |
| YTFILGFLVPLTIIC | 211 | P30874 | |
| FTALFPYLVLTIFLI | 211 | Q96N87 | |
| PYILLGFLFCAFVVV | 256 | Q5BKT4 | |
| ITLIIFFLCFLPYHT | 251 | Q9NS75 | |
| YAPVGFCLLVLRLFL | 31 | Q9Y679 | |
| FFFLIPLTVFGLSLA | 536 | O95436 | |
| YFGLTLFFVLVPSLL | 161 | Q5GH73 | |
| FVVLAFLTGVLCSYP | 61 | Q8IY95 | |
| ITTLLYSFFLGCFGV | 151 | Q9BX73 | |
| GIFYLTLFLILGTCT | 36 | Q9Y397 | |
| AYCFITIPSLAGIFT | 706 | Q7Z3J2 | |
| VVALFFGPCIFIYTR | 246 | Q8NGC2 | |
| LLCLFFSLPLFFIGC | 451 | O94956 | |
| FIPYLVFLFTCGIPV | 71 | Q9NSD5 | |
| LLLLYDVFFVFITPF | 346 | Q8TCT8 | |
| LIYTLRCGVFATFPI | 236 | Q9BSE2 | |
| VYGLSLLCFSALRPF | 256 | Q9BSE2 | |
| TFLLLFQYCLPLGFI | 216 | P0DQD5 | |
| RFPFYLSAVLCVFLF | 201 | Q687X5 | |
| LPLIFSLLFICFFGE | 6 | A0A1B0GTY4 | |
| LLYCFFLATVPALAE | 6 | Q6UW63 | |
| ILVTSGLFFAFDCPY | 71 | Q8IZN3 | |
| PGILIIIFYGISIFC | 46 | Q8IVQ6 | |
| FYLTFPLIFGLFIIL | 81 | O14668 | |
| CARYGSFPIFISALL | 301 | Q8TAD4 | |
| AVTYFITLCLFPGLE | 361 | Q7RTT9 | |
| CYFINFIIFGVFLPL | 1171 | Q01118 | |
| RAVSLCLFLLVFPAY | 381 | Q96MT1 | |
| TLIAIFPYAGLQFSC | 181 | Q9HC21 | |
| ILTTTGLFFVFDCPY | 101 | Q9NUE0 | |
| IGLLFPVFSVCYLIA | 336 | Q9UBN4 |